Hat mitgewirkt an:
-
SSTR antagonists as theranostic option in Merkel cell carcinoma
-
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
-
Preclinical evaluation of minigastrin analogs and proof-of-concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 patients with medullary thyroid cancer
-
Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer